Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPreferred Stock LiabilitiesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bowhead Specialty Holdings (BOW) Cash & Equivalents (2022 - 2025)

Bowhead Specialty Holdings' Cash & Equivalents history spans 3 years, with the latest figure at $197.9 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 48.88% year-over-year to $197.9 million; the TTM value through Sep 2025 reached $197.9 million, up 48.88%, while the annual FY2024 figure was $97.5 million, N/A changed from the prior year.
  • Cash & Equivalents for Q3 2025 was $197.9 million at Bowhead Specialty Holdings, up from $114.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $197.9 million in Q3 2025 and bottomed at $72.6 million in Q2 2023.
  • The 3-year median for Cash & Equivalents is $114.8 million (2025), against an average of $120.5 million.
  • The largest annual shift saw Cash & Equivalents surged 148.3% in 2024 before it crashed 36.33% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $126.7 million in 2023, then decreased by 23.04% to $97.5 million in 2024, then surged by 102.98% to $197.9 million in 2025.
  • Per Business Quant, the three most recent readings for BOW's Cash & Equivalents are $197.9 million (Q3 2025), $114.8 million (Q2 2025), and $88.0 million (Q1 2025).